摘要
复发/转移性鼻咽癌患者的治疗和预后具有较大的异质性,近5年来,随着化疗方案的不断优化和免疫治疗在实体瘤中取得的突破性进展,复发/转移性鼻咽癌的药物和治疗策略也发生了相应的变化。本文主要重点对不可局部治疗的复发/转移性鼻咽癌的治疗进展进行综述。
The treatment and prognosis of patients with recurrent/metastatic nasopharyngeal carcinoma(R/M NPC)are featured by strong heterogeneity.In the past five years,with the development of chemotherapy and the breakthrough of immunotherapy in solid tumors,the drugs and treatment strategies of R/M NPC have also undergone corresponding changes.This review mainly focuses on the treatment progress of R/M NPC.
作者
谢雪琪
葛中宽
胡漫
Xie Xueqi;Ge Zhongkuan;Hu Man(Department of Radiotherapy,Affiliated Cancer Hospital of Shandong First Medical University,Shandong Academy of Medical Sciences,Shandong Cancer Research Institute,Ji’nan 250117,China;Clinical Medical College of Weifang Medical University,Weifang 261053,China)
出处
《中华转移性肿瘤杂志》
2022年第2期177-181,共5页
Chinese Journal of Metastatic Cancer
关键词
鼻咽癌
复发
转移
免疫治疗
Nasopharyngeal carcinoma
Recurrent
Metastatic
Immunotherapy
